Antitumor activity of novel benzimidazole amidine derivatives of 7‐chloro‐4‐ aminoquinoline (CROSBI ID 675871)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija
Podaci o odgovornosti
Luka KRSTULOVIĆ, Marijana Jukić, Teuta Opačak‐Bernardi, Kristina Starčević, Miroslav Bajić, Ljubica Glavaš‐Obrovac
engleski
Antitumor activity of novel benzimidazole amidine derivatives of 7‐chloro‐4‐ aminoquinoline
As a part of our ongoing effort to prepare novel biologically active compounds, we have synthesized a short series of hybrid molecules in which 7‐chloro‐4‐aminoquinoline is linked to benzimidazole amidine moiety via m‐phenyl linker [1]. Several 7‐chloro‐4‐aminoquinoline based antimalarial therapeutics are tested for their anticancer activity, two of them (chloroquine and hydroxychloroquine) are currently investigated in clinical trials for cancer therapy [2]. Benzimidazole moiety is found in many known pharmaceuticals displaying, besides anticancer, a variety of biological effects [3]. Positively charged amidine groups are known for their cellular and nuclear uptake. Novel compounds were evaluated for their in vitro cytotoxic activity against normal epithelial (MDCK1) and carcinoma (HeLa, CaCo2, SW‐620, MCF‐7 and MDAMB231) cell lines using MTT assay.
hybrid molecules, 7‐chloro‐4‐aminoquinoline, benzimidazole amidines, anticancer activity
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
114-114.
2019.
objavljeno
Podaci o matičnoj publikaciji
26. hrvatski skup kemičara i kemijskih inženjera, Šibenik, 2019.
Galić, Nives ; Rogošić, Marko
Zagreb: Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI)
9789536894673
Podaci o skupu
26. hrvatski skup kemičara i kemijskih inženjera (26HSKIKI) ; 4. simpozij Vladimir Prelog
poster
09.04.2019-12.04.2019
Šibenik, Hrvatska